A detailed history of Cmg Global Holdings, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cmg Global Holdings, LLC holds 3,835 shares of ABBV stock, worth $678,603. This represents 0.45% of its overall portfolio holdings.

Number of Shares
3,835
Previous 3,835 -0.0%
Holding current value
$678,603
Previous $657,000 15.22%
% of portfolio
0.45%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $26,842 - $30,786
200 Added 5.5%
3,835 $515,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $10,743 - $13,593
100 Added 2.83%
3,635 $492,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $47,135 - $53,505
443 Added 14.33%
3,535 $381,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $10,521 - $11,721
100 Added 3.34%
3,092 $348,000
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $306,081 - $336,959
2,992 New
2,992 $324,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cmg Global Holdings, LLC Portfolio

Follow Cmg Global Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cmg Global Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cmg Global Holdings, LLC with notifications on news.